Goserelin

About

Therapy type: Hormone therapy

Therapy strategy: Gonadotropin-releasing hormone (GnRH) agonist

Mappings

NCI Thesaurus: Goserelin (ncit:C1374)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) ER positive, HER2-negative Invasive Breast Carcinoma Anastrozole, Goserelin, Ribociclib
Sensitivity (+) HER2-negative, PR positive Invasive Breast Carcinoma Anastrozole, Goserelin, Ribociclib
Sensitivity (+) ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Anastrozole, Goserelin, Ribociclib
Sensitivity (+) ER positive, HER2-negative Invasive Breast Carcinoma Goserelin, Letrozole, Ribociclib
Sensitivity (+) HER2-negative, PR positive Invasive Breast Carcinoma Goserelin, Letrozole, Ribociclib
Sensitivity (+) ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Goserelin, Letrozole, Ribociclib
Sensitivity (+) ER positive, HER2-negative Invasive Breast Carcinoma Anastrozole, Goserelin, Ribociclib
Sensitivity (+) HER2-negative, PR positive Invasive Breast Carcinoma Anastrozole, Goserelin, Ribociclib
Sensitivity (+) ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Anastrozole, Goserelin, Ribociclib
Sensitivity (+) ER positive, HER2-negative Invasive Breast Carcinoma Goserelin, Letrozole, Ribociclib
Sensitivity (+) HER2-negative, PR positive Invasive Breast Carcinoma Goserelin, Letrozole, Ribociclib
Sensitivity (+) ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Goserelin, Letrozole, Ribociclib